Phillies know they can’t afford to play it safe with Aidan Miller. Don’t rule out a 2025 debut.
Miller, the team's top prospect, has the potential to put together the kind of season that forces the Phillies to reevaluate ...
Strong revenue growth, margin expansion and FCF delivery in 2024, while investing significantly and reaching key transformation milestones
Regulated information Portfolio refocus nearly complete and major steps taken in transforming European and North American ...
Will Natco and Dr. Reddy’s bet on weight-loss drug Ozempic’s copy pay off?
In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.
Great Lakes Reports Fourth Quarter and Full Year 2024 Results
Fourth quarter net income of $19.7 millionFourth quarter Adjusted EBITDA of $40.2 millionFull year net income of $57.3 millionFull year Adjusted ...